COVID-19: Navigating the Pandemic: How will COVID-19 effect research studies and clinical trials?

April 16, 2020

Sponsored by

Webinar Description:

Pharma companies, biotechs, governments, academic institutions, nonprofits and others are all racing to develop a treatment, a cure and a vaccine for COVID-19.

In this Sanguine Speaker Series (S3) virtual fireside chat, we will discuss:

• How will COVID-19 effect research studies and clinical trials?
• How do we ensure the safety of our patients test subjects?
• Will patients have safety concerns about participating in research studies or clinical trials after this pandemic?
• What is COVID-19’s potential impact on the global pharmaceutical market?

Moderator:

Craig Lipset

Independent Advisor, Former Head of Clinical Innovation

Pfizer

Panelists:

Lisa Tindell

Vice President, Clinical Research Operations

Minneapolis Heart Institute Foundation

Sal Salamone

Editor in Chief

RTInsights.com

About Sanguine:

Sanguine, the leader in in-home specimen collection.